Abstract:Introduction: Porcine NICC xenotransplantation has been proposed as a novel treatment of type 1 diabetes. However T-cell-mediated rejection remains a major impediment to its clinical application. The ability to manufacture xenoantigen-specific Treg may be a strategy to achieve effective suppression. Previously, we identified a HLA-DR+CD27+ subset of Treg that was separated from xenoantigen-stimulated human Treg (XnTreg) and showed potent and xenoantigen-specific suppression in vitro. The aim of this study was to confirm their suppressive function and antigen specificity in vivo. Methods: Human Treg isolated from healthy donor peripheral blood mononuclear cells were expanded for 3 or 4 cycles with anti-CD3/CD28 beads and irradiated porcine PBMC as xenoantigen to produce antigen-stimulated Treg (XnTreg). Human XnTreg were separated by cell sorting using the Treg cell surface markers CD27 and HLADR into non-selected XnTreg, HLADR+CD27+ and HLADR+CD27+ depleted-Treg (Dep-Treg) subsets prior to cotransfer into NOD-SCID IL2rg-/- mice recipients of porcine NICC with autologous PBMC and Treg at a 1:25 ratio of Treg (4x10^5): PBMC (1x10^7). Serum, spleen and NICC xenografts were harvested from recipient mice at day 60 for analysis of xenograft survival and Treg function in vivo. Results: Human PBMC engraftment was confirmed by flow cytometry by day 60 after adoptive transfer. Mice reconstituted with human PBMC without Treg rejected their xenografts completely within 35 days. However, in mouse recipients of NICC xenografts that were reconstituted with human PBMC and HLADR+CD27+ Treg, immunohistochemical analysis revealed more intact NICC grafts and insulin positive-staining compared to those reconstituted with non-selected Xn Treg group at day 60. In the Dep-Treg group, very few insulin positive-staining cells were seen and a large number of human CD4 and CD8 Tcells infiltrated the islet graft. However in HLADR+CD27+Treg group there were few CD4 and CD8 cells surrounding but not infiltrating the islet graft. The highest serum c-peptide levels were found in the HLADR+CD27+ Treg (458.83±78.1 pmol/l) transferred group compared to Xn-Treg (196.3±76.8 pmol/l), Dep-Treg (123.4±46.5 pmol/l) or Pc-Treg (144.1±19.0 pmol/l) transferred groups. Immunofluorescent showed that HLADR+CD27+ Treg mediated islet xenograft protection was associated with a larger proportion of intragraft CD4+Foxp3+ Treg. Furthermore, the TaqMan Low Density Array analysis of human immune gene expression demonstrated upregulated expression of the Treg functional molecues (CTLA-4 and IL10) along with downregulated proinflammatory gene expression in mice co-transferred with HLADR+CD27+ Treg and PBMC. Conclusion: CD27+HLADR+ Treg were more potent than naïve Treg at preventing islet xenograft rejection and could be achieved at much smaller Treg:Tcell ratios suggesting they may be more specific for the xenograft and may have potential as an effective immunomodulatory cell therapy for transplantation. NSFC81201171, Hunan Provincial Natural Science Foundation of China 2017JJ3423.

Efficient peripheral construction of functional human regulatory CD4 +CD25 highFoxp3 + T cells in NOD/SCID mice grafted with fetal human thymus/liver tissues and CD34 + cells

Human Natural Regulatory T Cell Development, Suppressive Function, and Postthymic Maturation in a Humanized Mouse Model

Identification and Characterization of Foxp3+ Γδ T Cells in Mouse and Human

Presence of functional mouse regulatory CD4+CD25+T cells in xenogeneic neonatal porcine thymus-grafted athymic mice.

Efficient Generation of Human Alloantigen-Specific CD4+ Regulatory T Cells from Naive Precursors by CD40-activated B Cells

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

Reconstitution of a Functional Human Immune System in Immunodeficient Mice Through Combined Human Fetal Thymus/liver and CD34+ Cell Transplantation.

T-cell development and activation in humanized mice lacking mouse major histocompatibility complexes

The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.

Deficiency of Mouse CD4+CD25+Foxp3+ Regulatory T Cells in Xenogeneic Pig Thymus-Grafted Nude Mice Suffering from Autoimmune Diseases

Characterization of Protective Human CD4CD25 FOXP3 Regulatory T Cells Generated with IL-2, TGF-β and Retinoic Acid.

Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/− Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice

IN VIVO ANTI-CD45RB ANTIBODY-INDUCED REGULATORY T CELLS DEMONSTRATE SPECIES-SPECIFIC TOLERANCE TO DISCORDANT HUMAN XENOGENIC ISLETS

Efficient Induction and Expansion of Human Alloantigen-Specific Cd8 Regulatory T Cells from Naive Precursors by Cd40-Activated B Cells

De novo construction of T cell compartment in humanized mice engrafted with iPSC-derived thymus organoids

Efficient Induction and Expansion of Human Alloantigen-Specific CD8 Regulatory T Cells from Naive Precursors by CD40-Activated B Cells1

Ex Vivo Expanded Human Regulatory T Cells Delay Islet Allograft Rejection Via Inhibiting Islet-Derived Monocyte Chemoattractant Protein-1 Production in CD34+ Stem Cells-Reconstituted NOD-scid IL2rγnull Mice.

IDENTIFICATION AND ISOLATION OF HUMAN HLADR+CD27+TREG AS XENO-ANTIGEN TREG SUBSET FOR XENOTRANSPLANTATION

The Feature of TCR Vβ Subfamily T Cells Expansion in NOD/SCID Mice Transplanted with Human Cord Blood Hematopoietic Stem Cell.

Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.

Long-Term Human Immune Reconstitution, T-Cell Development, and Immune Reactivity in Mice Lacking the Murine Major Histocompatibility Complex: Validation with Cellular and Gene Expression Profiles